Doctors need more tools to quickly determine whether an antibiotic is truly needed, an expert tells MD+DI.
IVD - Industry Insight
A panel of IVD experts will discuss the latest in vitro diagnostic trends at the BIOMEDevice San Jose conference in December.
It's been a full year since Abbott closed its $5.3 billion acquisition of Alere, a deal that almost didn't happen.
Audrey Turley, of Nelson Labs, will speak at Medical Design & Manufacturing Minneapolis about biocompatibility issues related to medical devices including the move to more in vitro testing and the 2020 deadline for the new European Medical Device Regulation.
Diagnostics manufacturers and even medical device innovators can play roles, says an expert working to raise awareness.
Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
A recent scientific statement by the American Heart Association shines a spotlight on cardiovascular genomic testing and gives a nod to two such technologies that are currently on the market.
Medtech startup RenovaCare has developed a device to spray stem cells on burn injuries in an effort to regrow new skin. Here's the latest on the company's progress.
IBSchek, a blood test, can offer a diagnosis of irritable bowel syndrome without the long wait time and high costs of the conventional exclusionary pathway.
In addition to recommendations, guidance, and emergency use authorizations, FDA wants to do more to support development of Zika diagnostic tests.
On January 10, PricewaterhouseCoopers, the California Healthcare Institute, and BayBio released preliminary findings of its California Biomedical Industry 2012 Report from a survey of biomedical industry CEOs. The findings were released at a panel discussion with three CEOs active in the healthcare space: Rick Winningham, CEO of Theravance Stephen Cary, CEO of Omniox Alex Lukianov, CEO of Nuvasive MD+DI will provide a recap of the CEOs' reflections soon.